MedPath

Respiratory Critical Care Nurse Training Program

Not Applicable
Not yet recruiting
Conditions
Treatment Compliance
Morality
Interventions
Other: respiratory critical care support
Registration Number
NCT05941923
Lead Sponsor
Baqiyatallah Medical Sciences University
Brief Summary

The goal of this clinical trial study is to evaluate the clinical effectiveness of respiratory critical care nurses (RCCN) in improving outcomes for critically ill patients who require admission to the intensive care units (ICUs). The main question it aims to answer is: What is the effect of the respiratory critical care nurse in improving outcomes for critically ill patients? Participants will consist of critically ill patients who will be randomly allocated in a 1:1 ratio into two groups: the intervention group, who will receive specialized respiratory care from RCCN from the time they arrive in the emergency room until their discharge from the hospital, and the control group, who will receive only routine care.

Detailed Description

A randomized controlled clinical superiority trial with triple blinding and a two-arm parallel group design will be conducted at Baqiyatallah University of Medical Sciences in Tehran, Iran between November 22, 2023, and November 10, 2024. The aim of this study will to evaluate the clinical effectiveness of respiratory critical care nurses (RCCN) in improving outcomes for critically ill patients who require admission to the intensive care units (ICUs). Participants will consist of critically ill patients who will be randomly allocated in a 1:1 ratio into two groups: the intervention group, who will receive specialized respiratory care from RCCN from the time they arrive in the emergency room until their discharge from the hospital, and the control group, who will receive only routine care

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • They are at least 18 years old,
  • Critically ill patients who need critical care,
  • They have no history of heart disease, stroke, autoimmune disease, neuromuscular diseases, cancer, or cardio-respiratory arrest,
  • They are willing to participate in the study.
Exclusion Criteria
  • Patients with pregnancy and breastfeeding women
  • Patients at end-stage medical condition
  • Patients with planned withdrawal of treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention grouprespiratory critical care supportThe experimental group, who will receive specialized respiratory care from RCCN from the time they arrive in the emergency room until their discharge from the hospital
Primary Outcome Measures
NameTimeMethod
Mortality ratethrough study completion, an average of 3 months

The primary outcome of this study will be to compare mortality rates between two study groups.

Secondary Outcome Measures
NameTimeMethod
Treatment failuresthrough study completion, an average of 3 months

The secondary outcome will be the proportion of treatment failures, which is defined by a composite endpoint consisting of the need for non-invasive ventilation (NIV), intubation, or death

© Copyright 2025. All Rights Reserved by MedPath